Literature DB >> 3496579

Human lactoferrin stimulates thymidine incorporation into DNA of rat crypt cells.

B L Nichols, K S McKee, J F Henry, M Putman.   

Abstract

In a search for dietary factors that might stimulate enterocyte proliferation, we developed an assay for thymidine incorporation into DNA using harvested crypt cells from mature rat small intestine. Human colostrum stimulated a significant increase in thymidine incorporation into rat crypt cell DNA during a 60-min period of incubation. When the protein with biological activity was purified to a single peak by sequential ion exchange and gel filtration chromatography, it was found to have the characteristics of lactoferrin. The protein was identical to lactoferrin standards by sodium dodecyl sulfate polyacrylamide gel electrophoresis, isoelectric focusing, and double-diffusion immunologic precipitation. All available human lactoferrins stimulated thymidine uptake and all reacted with a lactoferrin polyclonal antibody. Human lactoferrin appears to be a potent activator of thymidine incorporation into DNA in incubated rat crypt cells, a nutritional function not previously reported.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496579     DOI: 10.1203/00006450-198706000-00011

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Oral repletion of iron induces free radical mediated alterations in the gastrointestinal tract of rat.

Authors:  K Srigiridhar; K M Nair; R Subramanian; L Singotamu
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells.

Authors:  Rulan Jiang; Veronica Lopez; Shannon L Kelleher; Bo Lönnerdal
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

3.  Bioactive recombinant human lactoferrin, derived from rice, stimulates mammalian cell growth.

Authors:  N Huang; D Bethell; C Card; J Cornish; T Marchbank; D Wyatt; K Mabery; R Playford
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-19       Impact factor: 2.416

4.  Microparticle-enhanced nephelometric immunoassay of lactoferrin in human milk.

Authors:  M L Cuillière; P Montagne; C Molé; M C Béné; G Faure
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

5.  Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.

Authors:  P H van Berkel; M E Geerts; H A van Veen; P M Kooiman; F R Pieper; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

6.  COUP-TF acts as a competitive repressor for estrogen receptor-mediated activation of the mouse lactoferrin gene.

Authors:  Y Liu; N Yang; C T Teng
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

Review 7.  Lactoferrin and necrotizing enterocolitis.

Authors:  Michael P Sherman
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

8.  Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation.

Authors:  T W Hutchens; J F Henry; T T Yip
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines.

Authors:  P D Siebert; B C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

10.  "Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice.

Authors:  Xueying Sun; Ruohan Jiang; Aneta Przepiorski; Shiva Reddy; Kate P Palmano; Geoffrey W Krissansen
Journal:  BMC Cancer       Date:  2012-12-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.